Sherman Michael A.

Sherman Michael A. is listed in filings as Director at Werewolf Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 13, 2025, including 9 public disclosures. Recent filings connect the profile to Werewolf Therapeutics, Inc. (HOWL) and Chimerix, Inc. (CMRX). The current snapshot covers public activity from Jun 21, 2024 to Jun 13, 2025. Reported amounts are shown as $34.8K to $4.9M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.